Survey of diagnostic and treatment practices for multiple sclerosis in Europe von Fernández, O., Delvecchio, M., Edan, G., Fredrikson, S., Gionvannoni, G., Hartung, H.‐P., Havrdova, E., Kappos, L., Pozzilli, C., Soerensen, P. S., Tackenberg, B., Vermersch, P., Comi, G.

Volltext

Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management von Fernández, O., Delvecchio, M., Edan, G., Fredrikson, S., Giovannoni, G., Hartung, H.‐P., Havrdova, E., Kappos, L., Pozzilli, C., Soerensen, P. S., Tackenberg, B., Vermersch, P., Comi, G.

Volltext

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis von Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C C, Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T, Leray, E

Volltext

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS von SELLEBJERG, F, BÖRNSEN, L, KHADEMI, M, KRAKAUER, M, OLSSON, T, FREDERIKSEN, J. L, SØRENSEN, P. S

Volltext

Reporting clinical trials: full access to all the data. Author's right to access to all data obtained in their study von Rosenberg, R N, Aminoff, M, Boller, F, Soerensen, P S, Griggs, R C, Hachinski, V, Hallett, M, Johnson, R T, Kennard, C, Lang, A E, Lees, A J, Lisak, R, Newsom-Davis, J, Pedley, T A, Selzer, M E, Zochodne, D

Volltext

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis : A dose-finding trial von FAZEKAS, F, LUBLIN, F. D, LI, D, FREEDMAN, M. S, HARTUNG, H. P, RIECKMANN, P, SOELBERG SØRENSEN, P, MAAS-ENRIQUEZ, M, SOMMERAUER, B, HANNA, K

Volltext

Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development von Hegen, H, Millonig, A, Bertolotto, A, Comabella, M, Giovanonni, G, Guger, M, Hoelzl, M, Khalil, M, Killestein, J, Lindberg, R, Malucchi, S, Mehling, M, Montalban, X, Polman, CH, Rudzki, D, Schautzer, F, Sellebjerg, F, Sørensen, PS, Deisenhammer, F

Volltext

Effects of infectious mononucleosis and HLA-DRB115 in multiple sclerosis von Nielsen, TR, Rostgaard, K, Askling, J, Steffensen, R, Oturai, A, Jersild, C, Koch-Henriksen, N, Sørensen, PS, Hjalgrim, H

Volltext

Using measurements of neutralizing antibodies: the challenge of IFN-β therapy von Hesse, D., Sørensen, P. S.

Volltext

Characteristics of patients with short and long survivals after detection of intracranial metastases from breast cancer von KAMBY, C, SOERENSEN, P. S

Volltext

Minocycline added to subcutaneous interferon beta -1a in multiple sclerosis: randomized RECYCLINE study von Soerensen, P S, Sellebjerg, F, Lycke, J, Faerkkilae, M, Creange, A, Lund, C G, Schluep, M, Frederiksen, J L, Stenager, E, Pfleger, C, Garde, E, Kinnunen, E, Marhardt, K

Volltext

FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4 super(+)CD25 super(high) T cells in multiple sclerosis von Sellebjerg, F, Krakauer, M, Khademi, M, Olsson, T, Soerensen, P S

Volltext

Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients von Jensen, P. E. H., Sellebjerg, F., Søndergaard, H. B., Sørensen, P. S.

Volltext

The Six Spot Step Test: a new measurement for walking ability in multiple sclerosis von Nieuwenhuis, M M, Van Tongeren, H, Sørensen, P S, Ravnborg, M

Volltext

Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis von Sellebjerg, F, Hedegaard, CJ, Krakauer, M, Hesse, D, Lund, H, Nielsen, CH, Søndergaard, HB, Sørensen, PS

Volltext

Gene expression analysis of interferon-β treatment in multiple sclerosis von Sellebjerg, F, Datta, P, Larsen, J, Rieneck, K, Alsing, I, Oturai, A, Svejgaard, A, Soelberg Sørensen, P, Ryder, LP

Volltext

Reply to Freedman and Burks von Soerensen, P S

Volltext

Natalizumab utilization and safety in the TYGRIS program in the European Union von Stangel, M, Soerensen, P S, Petersen, T, Vermersch, P, De Seze, J, Confavreux, C

Volltext

Confirmed association between multiple sclerosis and gene variations in interleukin-2 and interleukin-7 receptors in Danish multiple sclerosis patients von Soendergaard, H B, Sellebjerg, F, Nielsen, AMH, Ryder, L P, Soerensen, P S, Oturai, A

Volltext

Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis von Ravnborg, M, Bendtzen, K, Christensen, O, Jensen, PEH, Hesse, D, Tovey, MG, Sørensen, PS

Volltext